ArticleJAMA network open2024

Kidney Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor vs Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy for Thrombotic Microangiopathy.

Jianbo Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.